The mechanism of quercetin in treating intracerebral hemorrhage was investigated by network pharmacology and molecular docking

Zi-You Zhang,Xiao-Yu Lv,Xin-Pei Zhou,Hai-Tao Xiang,Yu-Song He,Xu-Yang Li,Ting-Ting Yan,Yang-Yang Zhong,Zhuang Li,Ben-Si Zhang
DOI: https://doi.org/10.1097/md.0000000000040010
IF: 1.6
2024-10-09
Medicine
Abstract:Intracerebral hemorrhage (ICH) is a form of stroke that is characterized by the formation of a hematoma within the brain parenchyma and the risk of blood entering the ventricles. Non-traumatic ICH can be classified as primary (spontaneous) or secondary. Although non-traumatic ICH only accounts for 10% to 20% of all strokes, [ 1 , 2 ] its mortality rate is still much higher than that of ischemic stroke. The pathophysiological process of ICH involves primary and secondary injuries. Primary injury is caused by mechanical stress caused by a hematoma, whereas secondary damage is caused by blood catabolites. These injuries can lead to white matter damage in the brain, which in turn affects the patient's neurological function and quality of life. For patients, the severity of white matter injury may have a significant impact on their prognosis. [ 3 ]
medicine, general & internal
What problem does this paper attempt to address?